−40KRW
−2.30 BKRW
53.75 BKRW
64.64 M
About HLB THERAPEUTICS
Sector
Industry
CEO
Ki-Hong An
Website
Headquarters
Seongnam-si
Employees (FY)
92
Founded
2000
ISIN
KR7115450009
FIGI
BBG000QCN543
HLB Therapeutics Co., Ltd. engages in the development and sale of vaccines and manufacture of electronic parts. It operates through the following business divisions: Vaccine, Electronics, and Bio division. The Vaccine business division engages in the wholesale of flu vaccines and other vaccines. The Electronics business division manufactures motors, pumps, and electronic components. The Bio business division develops ophthalmic disease treatment, skin wound treatment and glioblastoma treatment. The company was founded on June 7, 2000 and is headquartered in Seongnam-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 115450 is 12140 KRW — it has decreased by 2.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange HLB THERAPEUTICS stocks are traded under the ticker 115450.
115450 stock is 7.23% volatile and has beta coefficient of 2.53. Check out the list of the most volatile stocks — is HLB THERAPEUTICS there?
Yes, you can track HLB THERAPEUTICS financials in yearly and quarterly reports right on TradingView.
115450 stock has fallen by 4.18% compared to the previous week, the month change is a 21.52% rise, over the last year HLB THERAPEUTICS has showed a 143.98% increase.
115450 net income for the last quarter is −4.18 B KRW, while the quarter before that showed −1.00 B KRW of net income which accounts for −317.15% change. Track more HLB THERAPEUTICS financial stats to get the full picture.
Today HLB THERAPEUTICS has the market capitalization of 932.07 B, it has increased by 20.63% over the last week.
No, 115450 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 115450 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HLB THERAPEUTICS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 92.00 employees. See our rating of the largest employees — is HLB THERAPEUTICS on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HLB THERAPEUTICS technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HLB THERAPEUTICS stock shows the buy signal. See more of HLB THERAPEUTICS technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HLB THERAPEUTICS EBITDA is −697.51 M KRW, and current EBITDA margin is −0.68%. See more stats in HLB THERAPEUTICS financial statements.